Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHSE: 688192)
Health Care · Biotechnology · CN
CN¥59.00
-3.14% today · -28.8% 1Y
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHSE: 688192) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.08B.
Over the last twelve months the share price has lost 28.8%, trading between 35.73 and 84.91.
Tweenvest scores Dizal (Jiangsu) Pharmaceutical Co., Ltd. across four factors: quality 28/100, value 77/100. Its strongest factor is value.
688192 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.08B
- Revenue (TTM)
- $142.63M
- P/E
- —
- EPS
- -1.29
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- CN¥84.91
- 52-week low
- CN¥35.73
- Avg volume (3M)
- —
- Shares outstanding
- 465.17M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.53 | -1.60% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.95 | -0.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $147.78 | -0.67% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $548.74 | -0.74% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $827.02 | -0.78% |
| argenx SEENXTBR: ARGX | $64.17B | €895.40 | +1.84% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $155.61 | -2.03% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.